Show of HandsShow of Hands

Show Of Hands February 20th, 2012 12:00am

The FDA is reconsidering its 2010 rejection of an obesity drug that led to 37lbs average weight loss in trials, but may also increase heart risks. Should a drug's effectiveness dealing with an epidemic like obesity cause the FDA to loosen side-effect safe

1 Liked

Comments: Add Comment